Masimo | MASI - Net Income

Stock Price
178.47
Daily Change
0.12 0.07%
Monthly
0.10%
Yearly
14.68%
Q2 Forecast
174.88

Masimo reported $57.1M in Net Income for its fiscal quarter ending in March of 2026.





Net Income Change Date
Abbott USD 1.08B 699M Mar/2026
Accuray USD 2.54M 6.49M Dec/2024
Align Technology USD 112.77M 22.99M Mar/2026
AngioDynamics USD -6.35M 4.55M Sep/2025
Artivion USD 2.42M 4.07M Dec/2025
AtriCure USD 108K 1.65M Mar/2026
Avanos Medical USD 5.1M 6.4M Mar/2026
Baxter International USD -15M 1.11B Mar/2026
Becton, Dickinson and Co. USD -311M 693M Mar/2026
Boston Scientific USD 1.34B 669M Mar/2026
Dexcom USD 199.5M 67.8M Mar/2026
Edwards Lifesciences USD 380.7M 289.5M Mar/2026
General Electric Aerospace USD 1.9B 637M Mar/2026
Globus Medical USD 140.59M 21.63M Dec/2025
Haemonetics USD 44.74M 6.06M Dec/2025
Inogen USD -5.96M 373K Sep/2024
Insulet USD 91.1M 10.5M Mar/2026
Integra LifeSciences USD -4.62M 2.91M Mar/2026
Intuitive Surgical USD 821.5M 26.7M Mar/2026
Masimo USD 57.1M 11.2M Mar/2026
Medtronic USD 1.14B 231M Dec/2025
Orthofix International USD -2.22M 20.57M Dec/2025
Owens Minor USD -56.33M 93.95M Dec/2025
ResMed USD 398.73M 6.14M Mar/2026
Steris USD 220.3M 27.4M Mar/2026
Stryker USD 745M 104M Mar/2026
Tandem Diabetes Care USD -589K 20.58M Dec/2025
Teleflex USD -8.15M 706.18M Mar/2026
Thermo Fisher Scientific USD 1.65B 313M Mar/2026
Zimmer Biomet Holdings USD 238.1M 98.8M Mar/2026